JPRN-UMIN000003128已完成未知
Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxins - Supplemental treatment of rheumatoid arthritis with natural milk antibodies
Asama Chemical Co. Ltd.,0 个研究点目标入组 40 人开始时间: 2010年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with milk allergy
研究者
相似试验
已完成
不适用
Research into lower dosing of tofacitinib (Xeljanz®) when used in combination with cobicistat (Tybost®), a drug that reduces drug breakdowRheumatoid Arthritis, Psoriatic ArthritisNL-OMON26019Radboudumc30
进行中（未招募）
1 期
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisRheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
已完成
不适用
BIOmarker-driven DEcision Study with Adalimumab (BIODESA)Rheumatoid arthritisISRCTN61158084niversity Hospital Regensburg (Universitätsklinikum Regensburg) (Germany)60
招募中
1 期
Exploratory study for the treatment of rheumatoid arthritis by eliminating dampnessRheumatoid ArthritisITMCTR2000003354Guangdong Provincial Hospital of Chinese Medicine
已完成
4 期
RhEumatoid arthritis REtreatment with ultra-low dose Rituximab: Disease Outcome after Dose Optimizatiochronic inflammation of the joints1000381610023213Rheumatoid arthritisNL-OMON47117Sint Maartenskliniek140